Detalhe da pesquisa
1.
The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis.
Hepatology
; 79(2): 425-437, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611260
2.
Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
J Infect Dis
; 225(6): 1091-1099, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437567
3.
Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B.
J Hepatol
; 77(6): 1515-1524, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985545
4.
Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
Am J Gastroenterol
; 116(8): 1676-1685, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33840727
5.
Recent developments in the regulation of cholesterol transport by natural molecules.
Phytother Res
; 35(10): 5623-5633, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34327759
6.
Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment.
Hepatobiliary Pancreat Dis Int
; 20(5): 416-425, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34275749
7.
[Impact of the Timing of Traditional Chinese Medicine Therapy on the Therapeutic Effect and Prognosis of Severe Coronavirus Disease 2019].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 42(4): 521-530, 2020 Aug 30.
Artigo
em Zh
| MEDLINE | ID: mdl-32895105
8.
An Unusual Cause of Ascites in a Patient With Hepatitis B.
Gastroenterology
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070692
9.
Therapeutic outcome of dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Afr Health Sci
; 23(2): 416-421, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38223613
10.
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy.
J Gastroenterol
; 58(5): 481-493, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928343
11.
[Bioinformatic analysis of differentially expressed genes and immune cell infiltration in primary biliary cholangitis patients with poor response to ursodeoxycholic acid therapy].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
; 38(1): 16-23, 2022 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-35078571
12.
Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence.
Chin Med
; 17(1): 23, 2022 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35180857
13.
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.
J Ethnopharmacol
; 293: 115210, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398501
14.
High Expression of Ubiquitin-Specific Protease 39 and Its Roles in Prognosis in Patients with Hepatocellular Carcinoma.
Evid Based Complement Alternat Med
; 2021: 6233175, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34987596
15.
False positive anti-hepatitis A virus immunoglobulin M in autoimmune hepatitis/primary biliary cholangitis overlap syndrome: A case report.
World J Clin Cases
; 9(22): 6464-6468, 2021 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34435013
16.
A novel nomogram to predict evident histological liver injury in patients with HBeAg-positive chronic hepatitis B virus infection.
EBioMedicine
; 67: 103389, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34004423
17.
A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Clin Transl Gastroenterol
; 10(5): 1-12, 2019 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31033506
18.
Identification of key genes in nonalcoholic fatty liver disease progression based on bioinformatics analysis.
Mol Med Rep
; 17(6): 7708-7720, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29620197